Literature DB >> 3300587

Clonidine vs chlordiazepoxide in the management of acute alcohol withdrawal syndrome.

G R Baumgartner, R C Rowen.   

Abstract

To our knowledge, this is the first reported comparison of clonidine with benzodiazepine in the management of acute alcohol withdrawal syndrome. In a double-blind trial, 61 men experiencing acute alcohol withdrawal were randomly assigned to receive clonidine or chlordiazepoxide over a 60-hour treatment period. Clonidine was more effective than chlordiazepoxide at reducing alcohol withdrawal scale scores, systolic blood pressures, and heart rates over the entire study period. Clonidine was as good as chlordiazepoxide at improving Cognitive Capacity Screening Exam, Hamilton Anxiety Rating Scale, and Self-Rating Scale scores. Adverse drug reactions reported by each group were similar, though less nausea and vomiting were observed in the clonidine group. Clonidine may represent a new alternative agent for the management of acute alcohol withdrawal syndrome.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3300587

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  17 in total

Review 1.  Emergency management of acute alcohol problems. Part 1: Uncomplicated withdrawal.

Authors:  J M Etherington
Journal:  Can Fam Physician       Date:  1996-11       Impact factor: 3.275

2.  [Epidural and intrathecal administration of alpha 2-adreno-ceptor agonists for postoperative pain relief].

Authors:  M G Rockemann; W Seeling
Journal:  Schmerz       Date:  1996-04-25       Impact factor: 1.107

Review 3.  Cigarette smoking, nicotine dependence, and treatment.

Authors:  K L Sees
Journal:  West J Med       Date:  1990-05

Review 4.  Is it prime time for alpha2-adrenocepter agonists in the treatment of withdrawal syndromes?

Authors:  Timothy E Albertson; James Chenoweth; Jonathan Ford; Kelly Owen; Mark E Sutter
Journal:  J Med Toxicol       Date:  2014-12

Review 5.  Alcohol withdrawal syndromes: a review of pathophysiology, clinical presentation, and treatment.

Authors:  R C Turner; P R Lichstein; J G Peden; J T Busher; L E Waivers
Journal:  J Gen Intern Med       Date:  1989 Sep-Oct       Impact factor: 5.128

Review 6.  The USA experience with the clonidine transdermal therapeutic system.

Authors:  J F Burris
Journal:  Clin Auton Res       Date:  1993-12       Impact factor: 4.435

Review 7.  Critical care pharmacotherapy. A review.

Authors:  M Tryba; P J Kulka
Journal:  Drugs       Date:  1993-03       Impact factor: 9.546

8.  The pharmacokinetics of clonidine in high dosage.

Authors:  J Fauler; L Verner
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

Review 9.  Neurologic effects of alcoholism.

Authors:  I Diamond; R O Messing
Journal:  West J Med       Date:  1994-09

Review 10.  Recommended drug treatment strategies for the alcoholic patient.

Authors:  A Schaffer; C A Naranjo
Journal:  Drugs       Date:  1998-10       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.